BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6342003)

  • 1. Endogenously synthesized prostaglandins stimulate sympathetic nervous system activity.
    Güllner HG
    Prostaglandins Leukot Med; 1983 Mar; 10(3):345-8. PubMed ID: 6342003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of inhibition of prostaglandin synthesis on sympathetic nervous system function in man.
    Güllner HG; Lake CR; Bartter FC; Kafka MS
    J Clin Endocrinol Metab; 1979 Oct; 49(4):552-6. PubMed ID: 225346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catecholamine metabolism during heroin use.
    Schildkraut JJ; Meyer RE; Orsulak PJ; Mirin SM; Roffman M; Platz PA; Grab E; Randall ME; McDougle M
    Am J Psychiatry; 1977 May; 134(5):534-7. PubMed ID: 848581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary catecholamine metabolites in hyperkinetic boys treated with d-amphetamine.
    Shekim WO; Dekirmenjian H; Chapel JL
    Am J Psychiatry; 1977 Nov; 134(11):1276-9. PubMed ID: 910984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward a biochemical classification of depressive disorders. I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depressions.
    Schildkraut JJ; Orsulak PJ; Schatzberg AF; Gudeman JE; Cole JO; Rohde WA; LaBrie RA
    Arch Gen Psychiatry; 1978 Dec; 35(12):1427-33. PubMed ID: 727878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norepinephrine metabolism and clinical response to dextroamphetamine in hyperactive boys.
    Shekim WO; Dekirmenjian H; Chapel JL; Javaid J; Davis JM
    J Pediatr; 1979 Sep; 95(3):389-94. PubMed ID: 469661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of renal prostaglandins in sympathetically mediated renin relase in the rat.
    Campbell WB; Graham RM; Jackson EK
    J Clin Invest; 1979 Aug; 64(2):448-56. PubMed ID: 37256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary excretion of catecholamine metabolites in hyperkinetic child syndrome.
    Khan AU; Dekirmenjian H
    Am J Psychiatry; 1981 Jan; 138(1):108-10. PubMed ID: 7446760
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of prostaglandin synthesis inhibition on sympathetic-and parasympathetic-mediated coronary hemodynamic responses.
    Trimarco B; Cuocolo A; Ricciardelli B; Patrignani P; Volpe M; de Luca N; Condorelli M
    J Pharmacol Exp Ther; 1986 May; 237(2):589-99. PubMed ID: 3084760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of norepinephrine secretion and production.
    Hoeldtke RD; Cilmi KM; Reichard GA; Boden G; Owen OE
    J Lab Clin Med; 1983 May; 101(5):772-82. PubMed ID: 6339653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catecholamine metabolites in nonhyperactive boys with arithmetic learning disability: a pilot study.
    Shekim WO; Dekirmenjian H
    Am J Psychiatry; 1978 Apr; 135(4):490-1. PubMed ID: 637149
    [No Abstract]   [Full Text] [Related]  

  • 12. Norepinephrine-induced increase in sympathetic neuron-derived prostaglandins is independent of neuronal release mechanisms.
    Sherbourne CD; Gonzales R; Goldyne ME; Levine JD
    Neurosci Lett; 1992 May; 139(2):188-90. PubMed ID: 1608548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary excretion of MHPG and normetanephrine in attention deficit hyperactivity disorder.
    Baker GB; Bornstein RA; Douglass AB; Van Muyden JC; Ashton S; Bazylewich TL
    Mol Chem Neuropathol; 1993; 18(1-2):173-8. PubMed ID: 8466590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma catecholamines in man are not influenced by the inhibition of prostaglandin synthesis.
    Rubin P; Blaschke T
    Prostaglandins; 1979 Apr; 17(4):581-5. PubMed ID: 461821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Day-to-day intraindividual reliability and interindividual differences in monoamines excretion.
    Curtin F; Walker JP; Schulz P
    J Affect Disord; 1996 Jun; 38(2-3):173-8. PubMed ID: 8791186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interactions of prostaglandins with the sympathetic nervous system--a review.
    Güllner HG
    J Auton Nerv Syst; 1983 May; 8(1):1-12. PubMed ID: 6308093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary catecholamine metabolites distinguish different types of sympathetic neuronal dysfunction in patients with orthostatic hypotension.
    Kopin IJ; Polinsky RJ; Oliver JA; Oddershede IR; Ebert MH
    J Clin Endocrinol Metab; 1983 Sep; 57(3):632-7. PubMed ID: 6874892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of renal kallikrein and prostaglandin in the control of renin release.
    Suzuki S; Kobayashi M; Hashiba K
    Jpn Heart J; 1986 Jan; 27(1):83-93. PubMed ID: 2425102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-induced renin release: blockade by indomethacin in the rat.
    Campbell WB; Zimmer JA
    Clin Sci (Lond); 1980 May; 58(5):415-8. PubMed ID: 6993088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions among renal nerves, prostaglandins, and renal arterial pressure in the regulation of renin release.
    Osborn JL; Kopp UC; Thames MD; DiBona GF
    Am J Physiol; 1984 Nov; 247(5 Pt 2):F706-13. PubMed ID: 6388358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.